Stuart will be based at the company's Slough, UK headquarters near London and will be responsible for the global strategic development, process and quality management of Clinical Monitoring. He is also the Director of Clinical Operations for the UK.
"In today's sophisticated and highly regulated clinical research environment the need for rigorous processes is paramount to ensure that the clinical data collected are always of the highest quality," said Stuart. "This challenge is compounded by the fact that most clinical trials span different continents where regulations and collection procedures vary."
"Stuart's addition to our management group strengthens the global clinical team with an accomplished new member." Glenn Kerkhof Chiltern's CEO added, "Stuart has abundant experience overseeing the monitoring of complex clinical trials and has a passion for getting it right. We are delighted to have him on board."
Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 900 people with 15 offices across the United States, United Kingdom, Germany, France, Italy, Spain, Poland, Czech Republic, Ukraine, India and South Africa. Chiltern provides services including Phase I and laboratory support, Phase II - III Clinical Development, Staff Resourcing, Biometrics, Regulatory and Medical Affairs. For further information see http://www.chiltern.com.
For More Information Contact:
Catherine Lemercier Richard Baptista
Chiltern International, Inc. Chiltern International Ltd.
2111 Palomar Airport Road 171 Bath Road
Suite 200 Slough
Carlsbad Berkshire
CA 92011 SL1 4AA
Tel: 1 (760) 707 5025 Tel: 44 (0) 1753 512 000
Fax: 1 (760) 707 5022 Fax: 44 (0) 1753 511 116
Email: Email:
Catherine.Lemercier@chiltern.com Richard.Baptista@chiltern.com
